Binding was detected with biotinylated goat anti-human IgM -chain specific antibodies (Jackson Immunoresearch), followed by streptavidin conjugated to phycoerythrin (PE) (BD Biosciences)

Binding was detected with biotinylated goat anti-human IgM -chain specific antibodies (Jackson Immunoresearch), followed by streptavidin conjugated to phycoerythrin (PE) (BD Biosciences). with IgG anti-Ro (i.e., 70 with neonatal lupus and 33 without neonatal lupus). In these subjects the mean levels of IgM anti-Ro60 were significantly higher than in the newborns from non-autoimmune mothers. In contrast, levels of IgM anti-MDA in IgG anti-Ro exposed neonates were significantly lower than in neonates from non-autoimmune mothers. The presence or absence of neonatal lupus did not influence the total levels of IgM in the anti-Ro exposed newborns. Taken together, our studies provide evidence that the immune (S)-(+)-Flurbiprofen development of the natural IgM-repertoire may be affected, and become imprinted by, the transfer of maternal IgG into the fetus. Keywords: Neonatal immunity, repertoire, neonatal lupus, maternal IgG, malondialdehyde 1. INTRODUCTION Secreted immunoglobulins play essential roles in host defenses from microbial pathogens, (S)-(+)-Flurbiprofen and certain types of spontaneously arising (i.e., natural) antibodies are reported to reinforce fundamental innate pathways for maintaining tissue homeostasis [1C5](reviewed in [6]). Indeed, IgM, the first isotype expressed during immune development (reviewed in [7]), is detectable by the 14th week of human gestation [8, 9]. In both mice and humans autoantibodies are highly represented in the IgM-repertoires [10, 11], and these include natural antibodies that recognize oxidation-associated neo-antigens on apoptotic cells (ACs)[12, 13], such as IgM to phosphorylcholine (PC) in oxidized lipids and malondialdehyde (MDA) protein modifications that have been linked to protective properties [2, 3, 14, 15]. Furthermore, higher levels (S)-(+)-Flurbiprofen of IgM to the apoptosis-associated determinant, PC, correlate with protection from atherosclerotic plaque and cardiovascular events [14, 16, 17], as well as with lower overall clinical disease activity in SLE patients in some cohorts [14]. The processes that mold the early development of the IgM-repertoire are poorly Rabbit Polyclonal to Tip60 (phospho-Ser90) understood [18]. During gestation clinical infection can dramatically increase overall IgM levels [19] and induce pathogen-specific antibodies later detectable in umbilical cord blood [20], demonstrating the capacity of the prenatal immune system for antigen-specific responses. Even more relevant, ACs are continuously generated during development, including from the involution of the placenta [21]. Hence the clonal representation within the neonatal IgM-repertoire may in part be selected by oxidative stress-related neo-epitopes on ACs. In the murine immune system, the earliest arising tier of mature B cells, termed B-1 cells is also the dominant cellular source of natural antibodies. B-1 cells have a specialized repertoire [22] and response profiles believed to result from positive clonal selection of B-1 precursors by some non-protein autoantigens [23, 24]. In humans, (S)-(+)-Flurbiprofen an equivalent B-1 cell subset, bearing the CD43+ CD27+ CD70? phenotype, have been detected in the bloodstream of adults and in umbilical cord blood of newborns [25]. Spontaneous production of anti-PC antibodies by these B cells has also been reported [25]. During immune development, despite the indisputable benefits of maternal IgG transfer that augment fetal defenses, there are also uncommon clinical settings in which antibodies from the maternal immune system pose substantial pathogenic threats. Neonatal lupus (NL) represents a well-documented clinical syndrome caused by maternal IgG-autoantibodies reactive with the autoantigens, Ro52 (52 kDa SSA/Ro), Ro60 (60 kDa SSA/Ro), and La (48kDa SSB) that can form immune complexes containing single-stranded (ss)RNA [26]. During gestation, active placental transport mediated by the neonatal Fc receptor (FcRn) introduces maternal IgG that can include IgG anti-Ro antibodies into the fetal circulation. The transplacental transfer of these IgG-autoantibodies can result in cutaneous manifestations, and more seriously in congenital heart block that is associated with high morbidity and 15C30% fetal/neonatal mortality [27, 28]. Cardiac injury in NL has been suggested to be driven by maternal IgG anti-Ro antibodies that bind to RNA-containing complexes exposed on the surface.